API Agora, Inc.

Nasdaq agora.io


$ 3.55 $ 0.03 (0.85 %)    

Tuesday, 14-Oct-2025 12:45:41 EDT
QQQ $ 602.12 $ 6.90 (1.16 %)
DIA $ 463.94 $ 6.86 (1.5 %)
SPY $ 665.01 $ 7.70 (1.17 %)
TLT $ 90.69 $ 0.05 (0.06 %)
GLD $ 381.90 $ 3.57 (0.94 %)
$ 3.57
$ 3.50
$ 3.55 x 1,348
$ 3.56 x 400
$ 3.49 - $ 3.54
$ 2.53 - $ 6.99
241,725
na
333.2M
$ 1.76
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 agora-announces-expanded-support-for-openais-realtime-api

Agora's Conversational AI Engine offers key enhancements to the Realtime API for more natural communication and interaction...

 agora-sees-q3-sales-34000m-36000m

Agora (NASDAQ:API) sees Q3 sales of $34.000 million-$36.000 million.

 agora-partners-with-wizai-to-bring-enterprise-grade-ai-agent-solutions-to-the-market

Advanced AI agents from Agora and WIZ.AI can power call centers with multilingual support and contextual understandingSANTA CLA...

 agora-q4-adj-002-up-from-001-yoy-sales-3445m-down-from-3604m-yoy

Agora (NASDAQ:API) reported quarterly earnings of $0.02 per share. This is a 100 percent increase over earnings of $0.01 per sh...

 b-of-a-securities-upgrades-agora-to-buy-raises-price-target-to-6

B of A Securities analyst Daley Li upgrades Agora (NASDAQ:API) from Neutral to Buy and raises the price target from $3.1 to $6.

 agora-says-senior-management-team-voluntarily-entered-into-lock-up-period-expiring-on-december-31-2025

For the purpose of expressing confidence in the long term value of the Company, Mr. Bin (Tony) Zhao, founder, chairman and CEO ...

 iris-energy-arrowhead-pharmaceuticals-urban-outfitters-and-other-big-stocks-moving-higher-on-wednesday

U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Wednesday.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION